Gene | SNP | Heterozygotes with DAE | Mean DAE | SD | Min-Max | |
---|---|---|---|---|---|---|
BRCA1 | rs799917 | T>C | 44% (12/27) | 0.67 | 0.12 | 0.43-0.80 |
 |  | C>T | 26% (7/27) | 1.41 | 0.22 | 1.21-1.83 |
BRCA2 | rs144848 | C>A | 65% (24/37) | 1.60 | 0.55 | 1.24-3.62 |
C1qA | rs172378 | A>G | 69% (11/16) | 1.86 | 0.77 | 1.26-3.37 |
 |  | G>T | 29% (5/17) | 0.72 | 0.06 | 0.67-0.83 |
CCND3 | rs1051130 | T>G | 24% (4/17) | 1.36 | 0.11 | 1.25-1.51 |
 |  | C>A | 5% (2/37) | 0.79 | 0.01 | 0.78-0.80 |
EMSY | rs228611 | A>C | 5% (2/37) | 1.38 | 0.21 | 1.23-1.53 |
GPX1 | rs1050450 | C>T | 79% (11/14) | 1.32 | 0.09 | 1.23-1.50 |
GPX4 | rs713041 | C>T | 100% (21/21) | 6.46 | 2.97 | 2.5-11.31 |
MLH3 | rs175080 | NA | 0% (0/35) | NA | NA | NA |
MTHFR | rs1801133 | T>C | 82% (27/33) | 0.65 | 0.06 | 0.54-0.77 |
NBS1 | rs709816 | C>T | 14%(3/21) | 0.82 | 0.01 | 0.81-0.83 |
 |  | T>C | 33% (7/21) | 1.37 | 0.19 | 1.21-1.65 |
TP53 | rs1042522 | C>G | 100% (16/16) | 0.34 | 0.06 | 0.25-0.49 |
 |  | T>C | 17% (5/29) | 0.75 | 0.06 | 0.66-0.82 |
TRXR2 | rs1139793 | C>T | 31% (9/29) | 1.38 | 0.13 | 1.21-1.61 |